Yuan Wan, M.D., Ph.D.
Tel: +1 607-777-5477
Office: Biotechnology Building, Room BI 2625
Department of Biomedical Engineering
2008.08-2007.07 Biomedical Engineering, University of Texas at Arlington, Arlington TX
1999.09-2007.07 Clinical Medicine and Genetics, Medical School of Southeast University, Nanjing, China
2018.09- Assistant Professor, Biomedical Engineering, Binghamton University, Binghamton, NY
2015.05-2018.07 Postdoc, MiniBio Lab, The Pennsylvania State University, University Park, PA
2013.01-2013.06 Research Fellow, School of Chemical and Physical Science, Flinders University, Adelaide, Australia
2012.09 Visiting Scholar of Institut Charles Gerhardt, Ecole Nationale Superieure de Chimie, Montpellier, France
2012.04-2015.01 Research Associate, Mawson Institute & Ian Wark Research Institute, University of South Australia, Adelaide, Australia
2007.07-2008.07 Supervisor, Department of R&D, Shanghai Bio Corporation & National Engineering Center for Biochip, Shanghai, China
2003.09-2004.07 Clinic Intern in Jiangsu People's Hospital, Nanjing, China
Dr. Yuan Wan completed his M.S. and M.D. degrees in Genetics and Clinical Medicine at Southeast University Medical School in 2007. Later, he earned his Ph.D. degree in Biomedical Engineering at the University of Texas at Arlington in 2012. He worked at the Mawson Institute and the Ian Wark Research Institute, University of South Australia, as an early career researcher from 2012 to 2015. In 2013, he was awarded Adjunct Academic Status as a Research Fellow in the School of Chemical and Physical Sciences, Faculty of Science and Engineering, at Flinders University. From 2015 to 2018, he assumed a Postdoc position at the Pennsylvania State University. Dr. Wan has a solid background in interdisciplinary fields including Clinical Medicine, Genomics, and Biomedical Engineering. His research interests thus lie in the interdisciplinary areas of Life Science, Biomedical & Electrical Engineering, and Transnational Medicine. In particular, Dr. Wan's research focuses on the development of applications in clinical setting, such as separation and detection of disease related biomolecules, targeted drug delivery, design and fabrication of microfluidic devices and point-of-care devices. In addition, he is also interested in exploring nanobiotechnology to investigate pathophysiologic mechanism, which would redound to the development of corresponding diagnostic and therapeutic assays. He played a primary role in the initiation and completion of a few studies, which were highly successful as demonstrated by the outstanding publication outputs. So far, over 50 of peer-reviewed articles and conference full papers were published on Nature Biomedical Engineering, Chemical Society Review, Nano Today, Bioactive Materials, Biotechnology Advances, Cancer Research and other leading journals. Given the field of nanobiosensing and nanomedicine has undergone unprecedented growth in the last few years, and the rapid development has exerted significant influence over biomedicine, Dr. Wan inherently believes that nanobiotechnology can further expedite the application of research for disease prevention, screening, identification, and treatment.
Md Mofizur Rahman | Dr. Rahman earned his PhD in Material Science and Engineering from Saitama University in collaboration with RIKEN in Wako, Japan in 2019. He graduated from Khulna University in Bangladesh with a B.Pharm (Bachelor of Pharmacy) and an M.Pharm (Masters of Pharmacy). He started his career as a faculty member and worked at several universities in Bangladesh. After completing his PhD, he began working as an Assistant Professor in the Department of Pharmacy at Daffodil International University in Dhaka, Bangladesh. He took a study leave and joined Binghamton University as a postdoctoral researcher at the Department of Biomedical Engineering in 2022. He is currently developing new technologies for EV-based cancer detection.
Yi Wen | She obtained her B.Sc. degree in Pharmaceutical Science at Nanjing Tech University. She currently is a Ph.D. candidate in Biomedical Engineering at Binghamton University. Her research is focusing on isolation of extracellular vesicles, cargo analyses, and relevant clinical translation.
Komal Krishnaji Abhange | Komal has completed her Bachelor of Engineering in Biomedical Engineering from Mumbai University and her Master of Science in Biomedical Engineering from Binghamton University. She has worked and assisted on developing nanoparticle based drug delivery system to target bacterial biofilms as a part of her Master's program. Currently, she is pursuing her PhD degree in Biomedical Engineering at Binghamton University. Her research interest focuses on efficient preparation and enrichment of exosome-mimetic vesicles as cancer vaccine and drug delivery vesicles.
Yundi Chen | Yundi obtained his B.Sc. degree in Biopharmaceutical Technology at China Pharmaceutical University and M.S. degree in Biomedical Engineering at Binghamton University. He currently is a PhD candidate in Biomedical Engineering at Binghamton University.
Sushil Pokhrel | Master student; he is working on EV-based cancer immunotherapy. He is applying to a PhD program.
Ashely Soliwoda | Master student; she is working on EV-based drug delivery. She is applying to a PhD or MD program.
Peter Prisinzano | Master student; he is working on EV-based drug delivery
Andrea Russo | Mr. Russo got an offer from Barry-Wehmiller Design Group
Lauren Petersen | Miss Petersen secured a job at IsoPlexis
Daniella Ramos | She finished 2-month REU program in our lab.
Jillian Smollar | Miss. Smollar is a MSAT specialist at Regeneron Pharmaceuticals.
Ethan Blumenthal | Mr. Blumenthal is a Associate Quality Control Chemist at United Biomedical Inc.
Ernest Puletasi | Mr. Puletasi is working in UHS.
Guosheng Wang, M.D. | Dr. Wang completed his training on October 2020 and returned to China.
Jing Wang, M.D., Ph.D. | Dr. Wang completed his training on June 2020 and resumed his physician career in China.
Zachary Quinn | He received full scholarship and joined the department of BME at Duke University as a PhD candidate.
Fei Xue | He received his MS degree on July 30, 2020. Currently, he is working in Qihan Biotech.
Dawn Bordenave | An undergraduate student at Xavier University of Louisiana. She took 2-month REU program in our lab.
Parthmesh Sanjay Akolkar | Biomedical Engineer at Prime Healthcare
Neshat Sayah | She received full scholarship and joined Baylor University as a PhD candidate